Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer

Author(s):
Wit, D. de; Gelderblom, H.; Sparreboom, A.; Hartigh, J. den; Hollander, M. den; Konig-Quartel, J.M.C.; Hessing, T.; Guchelaar, H.J. (0000-0002-7085-1383); Erp, N.P. van
Published
2014
Publication type
Article / Letter to editor
SunitinibMidazolamPharmacokineticsPhenotyping
Date issued
2014-01-31
Language
English
Is part of
Cancer Chemotherapy and Pharmacology (2014), Vol. 73, no. 1, p. 87-96
hdl
1887/107644
doi
10.1007/s00280-013-2322-7